- BIAL SA
BIAL Announces Oral Presentation at GBA1 Meeting 2025
Porto, Portugal (OTE) - BIAL, an innovation-driven biopharmaceutical company focused on neurosciences and rare diseases, today announced that it will give an oral presentation on its potential disease-modifying...
- 02.06.2025, 11:40:32
- /
- OTE0003
- BIAL SA
BIAL Announces First Patient Out in its Phase 2 Clinical Trial of BIA 28-6156 - a Novel Therapy for GBA1 Parkinson's Disease
Porto, Portugal (OTE) - BIAL, a hundred-year-old innovation-driven biopharmaceutical company focused on neurosciences and rare diseases, announced that the first patient has completed the full dose regimen in the...
- 07.01.2025, 08:16:32
- /
- OTE0002
Alle Aussendungen
Alle Anhänge
